Residency · Tulsa, OK
Sponsored by Osteopathic Medical Education Consortium of Oklahoma, Inc. (OMECO)
The Update Immune-Regulatory Role of Pro- and Anti-Inflammatory Cytokines in Recurrent Pregnancy Losses.
International journal of molecular sciences · 2022 · 100 citations · Thanh Luu
The impact of reproductive hormones on T cell immunity; normal and assisted reproductive cycles.
Journal of reproductive immunology · 2024 · 38 citations · Thanh Luu
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 96 citations · Katherine Moxley
2025 American Society for Reproductive Immunology Guidelines for the Treatment of Recurrent Pregnancy Losses: Practice Recommendations From the ASRI Clinical Reproductive Immunology Fellowship.
American journal of reproductive immunology (New York, N.Y. : 1989) · 2025 · 18 citations · Thanh Luu
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 76 citations · Katherine Moxley
Retrospective Study of EMS Scene Times and Mortality in Penetrating Trauma Patients: Improving Transport Standards and Patient Outcomes.
The American surgeon · 2024 · 11 citations · Abigail Rosander
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.
Gynecologic oncology · 2021 · 71 citations · Katherine Moxley
Understanding the Impacts of the COVID-19 Pandemic on Small Businesses and Workers Using Quantitative and Qualitative Methods.
Annals of work exposures and health · 2023 · 10 citations · Carol Quijada